Sodium-glucose cotransporter 2 (SGLT2) inhibitors in nephrolithiasis: should we "gliflozin" patients with kidney stone disease?

被引：0
作者：
de Carvalho, Mauricio [1 ,2 ]
Heilberg, Ita Pfeferman [3 ]
机构：
[1] Pontif Univ Catol Parana, Fac Med, Escola Med, Curitiba, PR, Brazil
[2] Univ Fed Parana, Dept Clin Med, Curitiba, PR, Brazil
[3] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil
来源：
JORNAL BRASILEIRO DE NEFROLOGIA | 2024年 / 46卷 / 03期
关键词：
Nephrolithiasis; Kidney Calculi; Sodium-Glucose Transporter 2 Inhibitors;
D O I：
10.1590/2175-8239-JBN-2023-0146en
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The prevalence of nephrolithiasis is increasing worldwide. Despite advances in understanding the pathogenesis of lithiasis, few studies have demonstrated that specific clinical interventions reduce the recurrence of nephrolithiasis. The aim of this review is to analyze the current data and potential effects of iSGLT2 in lithogenesis and try to answer the question: Should we also "gliflozin" our patients with kidney stone disease?
引用
收藏
页数：5
相关论文
共 21 条
  • [1] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    [J]. KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
  • [2] Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation
    Anan, Go
    Hirose, Takuo
    Kikuchi, Daisuke
    Takahashi, Chika
    Endo, Akari
    Ito, Hiroki
    Sato, Shigemitsu
    Nakayama, Shingo
    Hashimoto, Hideaki
    Ishiyama, Katsuya
    Kimura, Tomoyoshi
    Takahashi, Kazuhiro
    Sato, Makoto
    Mori, Takefumi
    [J]. PHARMACOLOGICAL RESEARCH, 2022, 186
  • [3] Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
    Balasubramanian, Priyadarshini
    Wanner, Christoph
    Ferreira, Joao Pedro
    Ofstad, Anne Pernille
    Elsaesser, Amelie
    Zinman, Bernard
    Inzucchi, Silvio E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (07) : E3003 - E3007
  • [4] Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials
    Cosentino, Claudia
    Dicembrini, Ilaria
    Nreu, Besmir
    Mannucci, Edoardo
    Monami, Matteo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 155
  • [5] SGLT2 Inhibitors: The Sweet Success for Kidneys
    Dharia, Atit
    Khan, Abid
    Sridhar, Vikas S.
    Cherney, David Z., I
    [J]. ANNUAL REVIEW OF MEDICINE, 2023, 74 : 369 - 384
  • [6] SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases
    Di Costanzo, Assunta
    Esposito, Giovanni
    Indolfi, Ciro
    Spaccarotella, Carmen Anna Maria
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [7] Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate
    Harmacek, Dusan
    Pruijm, Menno
    Burnier, Michel
    Muller, Marie-Eve
    Ghajarzadeh-Wurzner, Arlene
    Bonny, Olivier
    Zanchi, Anne
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (06): : 1073 - 1075
  • [8] Empagliflozin in Patients with Chronic Kidney Disease
    Herrington, William G.
    Staplin, Natalie
    Wanner, Christoph
    Green, Jennifer B.
    Hauske, Sibylle J.
    Emberson, Jonathan R.
    Preiss, David
    Judge, Parminder
    Mayne, Kaitlin J.
    Ng, Sarah Y. A.
    Sammons, Emily
    Zhu, Doreen
    Hill, Michael
    Stevens, Will
    Wallendszus, Karl
    Brenner, Susanne
    Cheung, Alfred K.
    Liu, Zhi-Hong
    Li, Jing
    Hooi, Lai Seong
    Liu, Wen
    Kadowaki, Takashi
    Nangaku, Masaomi
    Levin, Adeera
    Cherney, David
    Maggioni, Aldo P.
    Pontremoli, Roberto
    Deo, Rajat
    Goto, Shinya
    Rossello, Xavier
    Tuttle, Katherine R.
    Steubl, Dominik
    Petrini, Michaela
    Massey, Dan
    Eilbracht, Jens
    Brueckmann, Martina
    Landray, Martin J.
    Baigent, Colin
    Haynes, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (02) : 117 - 127
  • [9] Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis
    Kristensen, Kasper B.
    Henriksen, Daniel P.
    Hallas, Jesper
    Pottegard, Anton
    Lund, Lars C.
    [J]. DIABETOLOGIA, 2021, 64 (07) : 1563 - 1571
  • [10] The Sweet Pee Model for Sglt2 Mutation
    Ly, Joseph P.
    Onay, Tuncer
    Sison, Karen
    Sivaskandarajah, Gavasker
    Sabbisetti, Venkata
    Li, Lingli
    Bonventre, Joseph V.
    Flenniken, Ann
    Paragas, Neal
    Barasch, Jon M.
    Adamson, S. Lee
    Osborne, Lucy
    Rossant, Janet
    Schnermann, Jurgen
    Quaggin, Susan E.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (01): : 113 - 123
123